Literature DB >> 11874818

The impact of chronic obstructive pulmonary disease on work loss in the United States.

Don D Sin1, Tania Stafinski, Ying Chu Ng, Neil R Bell, Philip Jacobs.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a rapidly growing public health problem in the United States and elsewhere. Although direct costs of COPD are well documented, the impact of COPD and its severity on labor force participation is not well known. Using population-based data from the Third National Health and Nutrition Examination Survey (NHANES III), we determined the adjusted relationship between COPD (and its severity) and labor force participation in the U.S. We used data from 12,436 participants involved in NHANES III; 1,073 of these participants (8.6% of the total) reported COPD. These participants were 3.9% (95% confidence interval, 1.3% to 6.4%) less likely to be in the labor force than those without COPD. Increasing severity of COPD was associated with decreased probability of being in the labor force (p for linear trend = 0.001). Mild, moderate, and severe COPD was associated with a 3.4%, 3.9%, and 14.4% reduction in the labor force participation rate relative to those without COPD. These data suggest that COPD has a considerable adverse impact on work force participation. Based on these data, we estimate that, in 1994, COPD was responsible for work loss of approximately $9.9 billion in the U.S.

Entities:  

Mesh:

Year:  2002        PMID: 11874818     DOI: 10.1164/ajrccm.165.5.2104055

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  40 in total

Review 1.  How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction.

Authors:  M A Puhan; H J Schünemann; M Frey; M Scharplatz; L M Bachmann
Journal:  Thorax       Date:  2005-05       Impact factor: 9.139

2.  Smokers with airway obstruction are more likely to quit smoking.

Authors:  M Bednarek; D Gorecka; J Wielgomas; M Czajkowska-Malinowska; J Regula; G Mieszko-Filipczyk; M Jasionowicz; R Bijata-Bronisz; M Lempicka-Jastrzebska; M Czajkowski; G Przybylski; J Zielinski
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

3.  ATF3 and extracellular matrix-related genes associated with the process of chronic obstructive pulmonary.

Authors:  Jia Ye; Li Wen; De-Ling Liu; Guo-xiang Lai
Journal:  Lung       Date:  2014-08-14       Impact factor: 2.584

4.  Sex differences in frequent ED use among those with multimorbid chronic diseases.

Authors:  Sadaf A Milani; Hannah Crooke; Linda B Cottler; Catherine W Striley
Journal:  Am J Emerg Med       Date:  2016-08-03       Impact factor: 2.469

5.  Employment and disability for work in patients with COPD: a cross-sectional study among Dutch patients.

Authors:  A M Kremer; T M Pal; A R J van Keimpema
Journal:  Int Arch Occup Environ Health       Date:  2006-04-08       Impact factor: 3.015

6.  Employment status and quality of life in patients with chronic obstructive pulmonary disease.

Authors:  Karin H Orbon; Tjard R Schermer; Joost W van der Gulden; Niels H Chavannes; Reinier P Akkermans; Onno P van Schayck; Chris van Weel; Hans T Folgering
Journal:  Int Arch Occup Environ Health       Date:  2005-05-13       Impact factor: 3.015

Review 7.  The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.

Authors:  Samuel Louie; Amir A Zeki; Michael Schivo; Andrew L Chan; Ken Y Yoneda; Mark Avdalovic; Brian M Morrissey; Timothy E Albertson
Journal:  Expert Rev Clin Pharmacol       Date:  2013-03       Impact factor: 5.045

8.  The sex factor: epidemiology and management of chronic obstructive pulmonary disease in British Columbia.

Authors:  Pat G Camp; Munaza Chaudhry; Howard Platt; Michael Roch; Jeremy Road; Donald Sin; Robert D Levy
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

9.  Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease.

Authors:  Anderson Chuck; Philip Jacobs; Irvin Mayers; Darcy Marciniuk
Journal:  Can Respir J       Date:  2008 Nov-Dec       Impact factor: 2.409

10.  Longer term exposure to secondhand smoke and health outcomes in COPD: impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.

Authors:  Mark D Eisner; Peyton Jacob; Neal L Benowitz; John Balmes; Paul D Blanc
Journal:  Nicotine Tob Res       Date:  2009-07-08       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.